go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

South Dakota rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $602,560 · 10th–90th $489,779$977,2370%20%10th90th$602,560Professionalmedian $489,779 · 10th–90th $457,088$588,8440%50%10th90th$489,779$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$977,237.22
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$588,843.66
Cigna
Setting
Professional
Modifier
Global
Typical Low
$457,088.19
Median
$457,088.19
Typical High
$575,439.94
Medica
Setting
Facility
Modifier
Global
Typical Low
$457,088.19
Median
$758,577.58
Typical High
$1,174,897.55
Medica
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$1,000,000.00
Typical High
$1,000,000.00
Midlands
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$630,957.34
Sanford Health Plan
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$537,031.80
Typical High
$537,031.80
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$467,735.14
Typical High
$741,310.24